Patent and Trademark Notice

November 8, 2022

Patent Notice

MedAvail, Inc. invests in research and development to help its customers differentiate in the retail, hospital and clinic markets with innovative remote pharmaceutical dispensing technology. MedAvail’s patent portfolio is a testament to its unique approach and world-class engineering team. With respect to MedAvail product(s) and/or service(s) being used, the following patents, as well as other international patents and patents pending, may apply: USA: 8,191,719; 8,267,310; 8,465,243; 8,557,145; 8,695,814; 8,738,177; 8,789,748; 8,849,449; 8,862,266; 9,036,894; 9,242,794; 9,721,418, Europe: EP2589029; Canada: 2,768,030; 2,771,014; 2,788,943; 2,802,916

Trademark Notice

MEDAVAIL®, MEDAVAIL MEDCENTER®, MEDAVAIL REMOTE DISPENSING SYSTEM®, MEDCENTER®, MEDOPS®, MEDPLATFORM® and SPOTRX™ are trademarks of MedAvail, Inc. and may not be used without permission.

The names of other companies, products and services are the property of their respective owner.

The materials available through this website and other websites owned or provided by MedAvail, Inc. (individually and collectively, the “Website”) are the property of MedAvail, Inc. or its licensors, and are protected by copyright, trademark or other intellectual property laws. You may view, copy and print pages from the Website only (1) for personal use, provided that you maintain all copyright trademark, and other proprietary rights or notices, (2) for communicating with MedAvail, Inc. about a company product or service, or (3) for placing an order with MedAvail, Inc. You may not otherwise use, reproduce, download, store, post, broadcast, transmit, modify, sell or make available to the public content from the Website without the prior written approval of MedAvail, Inc.